This paper describes the 5-hydroxytryptamine
3 (5-HT
3) receptor antagonism of Y-25130 ((±)-
N-(1-azabicyclo[2.2.2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3, 4-dihydro-2
H-1, 4-benzoxazine-8-carboxamide monohydrochloride) in the rat cerebral cortex, isolated rabbit heart and isolated guinea pig ileum. In an in vitro binding assay, Y-25130 inhibited the specific binding of [
3H]quipazine to 5-HT
3 receptors at the synaptic membranes of the rat cerebral cortex with a K; value of 2.9 nM, the same as that of ondansetron. Metoclopramide, 5-HT and 2-methyl-5-HT also showed an inhibitory effect, but their affinities for 5-HT
3 receptors were lower than that of Y-25130. Y-25130 showed low affinity for histamine H
1 receptors (IC
50 = 4.4 μM) but it could not reveal any affinities for the other receptors (5-HT
1A, 5-HT
2, dopamine D
1, dopamine D
2, α
1-adrenoceptor, α
2-adrenoceptor, muscarine and benzodiazepine) even at a 10 μM concentration. In the isolated rabbit heart, Y-25130 antagonized the indirect sympathomimetic responses to 5-HT (pA
2 value = 10.06) and this effect was more potent than that of metoclopramide. In the isolated longitudinal smooth muscle of the guinea pig ileum, concentration-contraction effect curves for 5-HT were biphasic in the presence of ketanserin. Y-25130 shifted to the right only in the second phase of concentration-effect curves for 5-HT (pA
2 value = 7.04) and its activity was more potent than that of metoclopramide. These results indicate that Y-25130 is a potent and selective 5-HT
3 receptor antagonist.
View full abstract